Work

A first-in-human phase I study of 4SC-201, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumors

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.3530

Authors: A. T. Brunetto, J. E. Ang, R. Lal, D. Olmos, S. Frentzas, A. Mais, B. Hauns, M. Mollenhauer, G. Lahu, J. S. de Bono

Institution: Royal Marsden Hospital

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2280044053

Cites:

Cited by: 8

Related to: 10